Page last updated: 2024-11-08

xestospongin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

xestospongin B: structure given in first source; isolated from the sponge Xestospongia sp. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10390264
CHEMBL ID516249
MeSH IDM0210535

Synonyms (3)

Synonym
xestospongin b
CHEMBL516249
(1s,8s,10r,15r,22s,29r,32r)-32-methyl-9,30-dioxa-11,25-diazapentacyclo[20.6.2.28,11.010,15.025,29]dotriacontan-1-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1894968Anticancer activity against human BT-474 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay2021European journal of medicinal chemistry, Aug-05, Volume: 220Discovery of cytotoxic natural products from Red Sea sponges: Structure and synthesis.
AID336593Cytotoxicity against mouse L1210 cells1992Journal of natural products, Oct, Volume: 55, Issue:10
Two new alkaloids from Xestospongia sp., a New Caledonian sponge.
AID336594In vivo antitumor activity against mouse P388 cells1992Journal of natural products, Oct, Volume: 55, Issue:10
Two new alkaloids from Xestospongia sp., a New Caledonian sponge.
AID336592Cytotoxicity against human KB cells1992Journal of natural products, Oct, Volume: 55, Issue:10
Two new alkaloids from Xestospongia sp., a New Caledonian sponge.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's4 (36.36)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]